iMediSync Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

iMediSync General Information

Description

Developer of an AI-driven digital mental healthcare platform designed to advance brain and heart health assessment and management. The company's platform offers wireless dry EEG and HRV measurement devices, AI-based brainwave analysis, and standardized biomarker modeling, enabling clinicians and researchers to diagnose, monitor, and improve mental well-being with precision and efficiency.

Contact Information

Website
www.imedisync.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 411, Teheran-ro, Gangnam-gu
  • 15th Floor, Samseong-dong, Seongdam Building
  • Seoul, 06160
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
LOHAS & Wellness, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 411, Teheran-ro, Gangnam-gu
  • 15th Floor, Samseong-dong, Seongdam Building
  • Seoul, 06160
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iMediSync Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator Completed Generating Revenue
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC (Series C) 03-Feb-2022 Completed Generating Revenue
5. Later Stage VC (Series B) 01-Apr-2020 Completed Generating Revenue
4. Later Stage VC (Series A) 01-Jan-2018 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
2. Angel (individual) 01-Jan-2017 $400K $800K Completed Generating Revenue
1. Seed Round 01-Jan-2016 $500K $400K Completed Generating Revenue
To view iMediSync’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

iMediSync Patents

  • 30

    Total Documents Applications and Grants

  • Total Patents Families

  • 16

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

iMediSync Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024172440-A1 Method, device and computer program for providing therapy through brain wave data analysis Inactive 14-Feb-2023
US-20250360333-A1 Method, device and recording medium for providing therapy through brain wave data analysis Pending 14-Feb-2023
WO-2024135885-A1 Artificial intelligence-based biometric data quality evaluation method, device, and computer program for securing quality-verified biometric data Inactive 21-Dec-2022
US-20250253059-A1 Digital phenotyping method, apparatus, and computer program for drug response classification and prediction Pending 25-Oct-2022
WO-2024090640-A1 Digital phenotyping method, device, and computer program for drug response classification and prediction Inactive 25-Oct-2022 G16H50/20
To view iMediSync’s complete patent history, request access »

iMediSync Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

iMediSync Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
INSPIRA () Corporation Minority
New England Medical Innovation Center Accelerator/Incubator Minority
Pathway Partners (Korea) Venture Capital Minority
Withwin Investment Venture Capital Minority
A Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

iMediSync FAQs

  • When was iMediSync founded?

    iMediSync was founded in 2012.

  • Where is iMediSync headquartered?

    iMediSync is headquartered in Seoul, South Korea.

  • What is the size of iMediSync?

    iMediSync has 15 total employees.

  • What industry is iMediSync in?

    iMediSync’s primary industry is Diagnostic Equipment.

  • Is iMediSync a private or public company?

    iMediSync is a Private company.

  • What is iMediSync’s current revenue?

    The current revenue for iMediSync is .

  • How much funding has iMediSync raised over time?

    iMediSync has raised $14.3M.

  • Who are iMediSync’s investors?

    INSPIRA (), New England Medical Innovation Center, Pathway Partners (Korea), Withwin Investment, and A Ventures are 5 of 10 investors who have invested in iMediSync.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process